Resistant hypertension and the birmingham hypertension square

Current Hypertension Reports

Volumn 3, Issue 3, 2001, Pages 203-208

  Felmeden, Dirk C ^a   Lip, Gregory Y H ^a  

^a CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

BLOOD PRESSURE; DRUG COMBINATION; DRUG EFFECT; HUMAN; HYPERTENSION; REVIEW; VASCULAR RESISTANCE;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DRUG THERAPY, COMBINATION; HUMANS; HYPERTENSION; VASCULAR RESISTANCE;

EID: 0035375119     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-001-0039-1     Document Type: Article

References (55)

1. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997, 157:2413-2446.
2. Cornoni-Huntley J., LaCroix AZ, Havlik RJ: Race and sex differentials in the impact of hypertension in the United States. Arch Intern Med 1989, 149:780-788.
3. Shaper AG, Ashby D, Pocock SJ: Blood pressure and hypertension in middle-aged British men. J Hypertens 1988, 6:367-374.
4. Collins R, Peto R, MacMahon S: Blood pressure, stroke and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised trials in their epidemiological context. Lancet 1990, 335:827-838.
5. Guidelines Subcommittee: 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension. J Hypertens 1999, 17:151-183.
6. Avanzini F, Alli C, Bettelli G, et al.: Antihypertensive efficacy and tolerability of different drug regimens in isolated systolic hypertension in the elderly. Eur Heart J 1994, 15:206-212.
7. SHEP Cooperative Research Group: Prevention of stroke by antihypertensive drug therapy in the person with isolated systolic hypertension. JAMA 1991, 265:3255-3264.
8. MRC Working Party: MRC trial of mild hypertension. Br Med J 1985, 291:97-104.
9. Burt VL, Cutler JA, Higgins M, et al: Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population: data from the health examination surveys, 1960 to 1991. Hypertension 1995, 26:60-69.
10. Yakovlevitch M, Black HR: Resistant hypertension in a tertiary care clinic. Arch Intern Med 1991, 151:1786-1792.
11. Klein LE: Compliance and blood pressure control. Hypertension 1988, 2(suppl II):II61-II64.
12. Danielson M, Dammstrom B: The prevalence of secondary and curable hypertension. Acta Med Scand 1981, 209:451-455.
13. Rudnick KV, Sackett DL, Hirst S, Holmes C: Hypertension in a family practice. Can Med Assoc J 1977, 117: 492-497.
14. Berglund G, Andersson O, Wilhelmsen L: Prevalence of primary and secondary hypertension: studies in a random population sample. Br Med J 1976, 2:554-556.
15. Wilhelmsen L, Berglund G: Prevalence of primary and secondary hypertension. Am Heart J 1977, 94:543-546.
16. Brown MJ, Haydock S: Pathoaetiology, epidemiology and diagnosis of hypertension. Drugs 2000, 59(suppl 2):1-12.
17. Waeber B, Scherrer U, Petrillo A, et al.: Are some hypertensive patients overtreated? A prospective study of ambulatory blood pressure recording. Lancet 1987, 2:732-744.
18. Mejia AD, Egan BM, Schork N.J., Zweifler AL: Artefacts in measurement of blood pressure and lack of target organ involvement in the assessment of patients with treatment resistant hypertension. Ann Intern Med 1990, 112: 270-277.
19. Schotte DE, Stunkard AJ: The effect of weight reduction on blood pressure in 301 obese patients. Arch Intern Med 1990, 150:1701-1704.
20. Puddey IB, Beilin LJ, Vandongen R: Regular alcohol use raises blood pressure in treated hypertensive subjects: a randomised controlled trial. Lancet 1987, 1:647-651.
21. Groppelli A, Giorgi DM, Omboni S, et al: Persistent blood pressure increase induced by heavy smoking. J Hypertens 1992, 10: 495-499.
22. Messerli FH, Ventura HO, Amodeo C: Osler's maneuver and pseudohypertension. N Engl J Med 1985, 312: 1548-1551.
23. Johnson AG, Nguyen TV, Day RO: Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis. Ann Intern Med 1994, 121:289-300.
24. Materson BJ, Reda DJ, Cushman W.C., et al.: Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. N Engl J Med 1993, 328:914-921.
25. Clark LT: Improving compliance and increasing control of hypertension: needs of special hypertensive populations. Am Heart J 1991, 121(2 Pt 2):664-669.
26. Nussberger J, Waeber B, Brunner HR: Plasma angiotensin II and the antihypertensive action of angiotensin-converting enzyme inhibition. Am J Hypertens 1989, 2:286-293.
27. Radevski I, Skudicky D, Candy G., et al.: Antihypertensive monotherapy with nisoldipine CC is superior to enalapril in black patients with severe hypertension. Am J Hypertens 1999, 12(2 Pt 1):194-203.
28. Hall WD: Pathophysiology of hypertension in blacks. Am J Hypertens 1990, 3(12 Pt 2):366S-371S.
29. Dickerson JE, Hingorani AD, Ashby M.J., et al.: Optimisation of antihypertensive treatment by crossover rotation of four major classes. Lancet 1999, 353:2008-2013.
30. Staessen JA, Fagard R, Thijs L, et al.: Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997, 350:757-764.
31. Hanson L, Zanchetti A, Carruthers SG, et al.: HOT Study Group. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998, 351:1755-1762.
32. Nifedipine-Atenolol Study Review Committee: Nifedipine and atenolol singly and combined for treatment of essential hypertension: comparative multicentre study in general practice in the United Kingdom. Br Med J (Clin Res Ed) 1988, 296:468-472.
33. Medical Research Council Working Party: MRC trial of treatment of mild hypertension: principal results. Br Med J (Clin Res Ed) 1985, 291:97-104.
34. SHEP Cooperative Research Group: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991, 265:3255-3264.
35. Frishman WH, Bryzinski BS, Coulson L.R., et al.: A multi-factorial trial design to assess combination therapy in hypertension. Treatment with bisoprolol and hydrochlorothiazide. Arch Intern Med 1994, 154:1461-1468.
36. Soffer BA, Wright JT, Jr, Pratt JH, et al.: Effects of losartan on a background of hydrochlorothiazide in patients with hypertension. Hypertension 1995, 26:112-117.
37. Zezulka AV, Gill JS, Dews I, et al: Comparison of enalapril and bendrofluazide for treatment of systemic hypertension. Am J Cardiol 1987, 59:630-633.
38. Brouwer RM, Bolli P, Erne P., et al.: Antihypertensive treatment using calcium antagonists in combination with captopril rather than diuretics. J Cardiovasc Pharmacol 1985, 7(Suppl 1):S88-S91.
39. Singer DR, Markandu ND, Cappuccio F.P., MacGregor GA: Studies of captopril alone and in combination with the benzothiazepine, diltiazem or the dihydropyridine nifedipine in treating essential hypertension. J Cardiovasc Pharmacol 1991, 18(Suppl 9):S51-S54.
40. MacGregor GA, Markandu ND, Smith S.J., Sagnella GA: Captopril: contrasting effects of adding hydrochlorothiazide, propranolol, or nifedipine. J Cardiovasc Pharmacol 1985, 7(Suppl 1):S82-S87.
41. MacGregor GA, Cappuccio FP: Lack of effect of a diuretic added to diltiazem. J Hum Hypertens 1997, 11: 249-250.
42. Zezulka AV, Gill JS, Beevers DG: The effects of bendroflumethi-azide added to nifedipine in patients with hypertension. J Clin Pharmacol 1987, 27:41-45.
43. Graves JW, Bloomfield RL, Buckalew VM Jr. Plasma volume in resistant hypertension: guide to pathophysiology and therapy. Am J Med Sci 1989, 298:361-365.
44. Cappucino FP, Makanuda ND, Whithcer F, MacGregor GA: Doxazosin in combination therapy for resistant hypertension. J Hypertens 1994, 12(Suppl 3):S108.
45. Forslund T, Fyhrquist F, Hortling L: Sustained antihypertensive effect of captopril combined with diuretics and beta-adrenergic blocking drugs in patients with resistant hypertension. Acta Med Scand 1983, 213: 299-303.
46. Ramsey LE, Parnell L, Walker PC: Comparison of nifedipine, prazosin, and hydralazine added to treatment of hypertensive patients uncontrolled by thiazide diuretic plus beta-blocker. Postgrad Med J 1987, 63:99-103.
47. Potter JF, Beevers DG: Comparison of nifedipine and captopril as third-line agents in hypertensive patients uncontrolled with beta-blocker and diuretic therapy. J Clin Pharmacol 1987, 27:410-404.
48. Bevan EG, Pringle SD, Walker P.C., et al.: Comparison of captopril, hydralazine, and nifedipine as third drug in hypertensive patients. J Hum Hypertens 1993, 7:83-88.
49. McAreavey D, Ramsy LE, Latham L, et al: "Third drug" trial: comparative study of antihypertensive agents added to treatment when blood pressure remains uncontrolled by a beta-blocker plus thiazide diuretic. BMJ 1984, 288:106-111.
50. Lip GYH, Beevers M, Beevers DG: The 'Birmingham Hypertension Square' for the optimum choice of add-in drugs in the management of resistant hypertension. J Hum Hypertens 1998, 12:761-763.
51. Nalbantgil I, Onder R, Kiliccioglu B., Turkoglu C: Combination therapy with verapamil and nitrendipine in patients with hypertension. J Hum Hypertens 1993, 7:305-308.
52. ALLHAT Collaborative Research Group: Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA 2000, 283:1967-1975.
53. Marshall HJ, Beevers DG: b-Adrenoceptor blocking drugs and female urinary incontinence: prevalence and reversibility. Br J Clin Pharmacol 1996, 42:507-509.
54. Beevers DG, Hamilton M, Fairman M.J., Harpur JE: The influence of antihypertensive treatment over the incidence of cerebral vascular disease. Postgrad Med J 1973, 49:905-907.
55. Isles CG, Walker LM, Beevers G.D., et al.: Mortality in patients of the Glasgow Blood Pressure Clinic. J Hypertens 1986, 4:141-156.